Tenet Healthcare Corp. (THC) Misses Q4 EPS by 4c; Raises FY12 EBITDA Outlook
Tweet
Share
E-mailGet Alerts THC Hot Sheet
Price: $267.05 +0.10%
Financial Fact:
Income from continuing operations, net of tax: -9M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Income from continuing operations, net of tax: -9M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Tenet Healthcare Corp. (NYSE: THC) reported Q4 EPS of $0.10, $0.04 worse than the analyst estimate of $0.14. Revenue for the quarter came in at $2.23 billion versus the consensus estimate of $2.4 billion.
Raised its FY12 adj-EBITDA guidance from $1.2-$1.3 billion to $1.225-$1.35 billion.
For earnings history and earnings-related data on Tenet Healthcare Corp. (THC) click here.
Raised its FY12 adj-EBITDA guidance from $1.2-$1.3 billion to $1.225-$1.35 billion.
For earnings history and earnings-related data on Tenet Healthcare Corp. (THC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Lument Finance Trust (LFT) Misses Q2 EPS by 17c
- Assembly Biosciences (ASMB) Tops Q2 EPS by 53c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
